Literature DB >> 27354132

The Promise of the Abscopal Effect and the Future of Trials Combining Immunotherapy and Radiation Therapy.

C Bryce Johnson1, Reshma Jagsi2.   

Abstract

Mesh：

Year:  2016        PMID： 27354132     DOI： 10.1016/j.ijrobp.2016.02.067

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  15 in total

1.  Improved time to disease progression in the brain in patients with melanoma brain metastases treated with concurrent delivery of radiosurgery and ipilimumab.

Authors:  Tijana Skrepnik; Srinath Sundararajan; Haiyan Cui; Baldassarre Stea
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

2.  Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes.

Authors:  Sayeda Yasmin-Karim; Bashkim Ziberi; Johanna Wirtz; Noella Bih; Michele Moreau; Romy Guthier; Victoria Ainsworth; Juergen Hesser; G Mike Makrigiorgos; Michael D Chuong; Xiao Wei; Paul L Nguyen; Wilfred Ngwa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-09-13       Impact factor: 7.038

3.  Tumor Heterogeneity Research and Innovation in Biologically Based Radiation Therapy From the National Cancer Institute Radiation Research Program Portfolio.

Authors:  Jeffrey C Buchsbaum; Michael G Espey; Ceferino Obcemea; Jacek Capala; Mansoor Ahmed; Pataje G Prasanna; Bhadrasain Vikram; Julie A Hong; Beverly Teicher; Molykutty J Aryankalayil; Michelle A Bylicky; C Norman Coleman
Journal:  J Clin Oncol       Date:  2022-03-04       Impact factor: 50.717

4.  Combination therapy with PD-1/PD-L1 blockade: An overview of ongoing clinical trials.

Authors:  C Bryce Johnson; Shwe Y Win
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

Review 5.  A critical review of recent developments in radiotherapy for non-small cell lung cancer.

Authors:  Sarah Baker; Max Dahele; Frank J Lagerwaard; Suresh Senan
Journal:  Radiat Oncol       Date:  2016-09-06       Impact factor: 3.481

6.  AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies.

Authors:  Ferdinando Maria Milazzo; Anna Maria Anastasi; Caterina Chiapparino; Antonio Rosi; Barbara Leoni; Loredana Vesci; Fiorella Petronzelli; Rita De Santis
Journal:  Oncotarget       Date:  2017-04-04

Review 7.  Radiation effects on antitumor immune responses: current perspectives and challenges.

Authors:  Thomas Walle; Rafael Martinez Monge; Adelheid Cerwenka; Daniel Ajona; Ignacio Melero; Fernando Lecanda
Journal:  Ther Adv Med Oncol       Date:  2018-01-18       Impact factor: 8.168

Review 8.  Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.

Authors:  Jun Gong; Thang Q Le; Erminia Massarelli; Andrew E Hendifar; Richard Tuli
Journal:  J Immunother Cancer       Date:  2018-06-04       Impact factor: 13.751

9.  Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma.

Authors:  Jacob J Adashek; Meghan Salgia; Nazli Dizman; Jonathan Kessler; Sumanta K Pal
Journal:  Case Rep Oncol       Date:  2018-05-17

Review 10.  Checkpoint Inhibition: Will Combination with Radiotherapy and Nanoparticle-Mediated Delivery Improve Efficacy?

Authors:  Purushottam Lamichhane; Neha P Amin; Manuj Agarwal; Narottam Lamichhane
Journal:  Medicines (Basel)       Date:  2018-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.